Theodore Karrison to Proto-Oncogene Proteins c-bcl-2
This is a "connection" page, showing publications Theodore Karrison has written about Proto-Oncogene Proteins c-bcl-2.
Connection Strength
0.188
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
Score: 0.147
-
Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression. Clin Cancer Res. 2000 Oct; 6(10):4043-8.
Score: 0.041